Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia

Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia

Abstract Background The constitutive hyper-activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathways has frequently been associated with acute myeloid leukemia (AML). While many inhibitors targeting these pathways have been deve...

Full description

Bibliographic Details
Main Authors: Yanan Gao, Juan Gao, Minghao Li, Yawei Zheng, Yajie Wang, Hongyan Zhang, Weili Wang, Yajing Chu, Xiaomin Wang, Mingjiang Xu, Tao Cheng, Zhenyu Ju, Weiping Yuan
Format: Article
Language:English
Published: BMC 2016-04-01
Series:Journal of Hematology & Oncology
Subjects:
Rheb1
mTORC1
MLL-AF9
Leukemia
Rapamycin
3BDO
Online Access:http://link.springer.com/article/10.1186/s13045-016-0264-3

Internet

http://link.springer.com/article/10.1186/s13045-016-0264-3

Similar Items